FDA clears BD’s advanced diagnostic system to combat antimicrobial resistance

FDA clears BD’s advanced diagnostic system to combat antimicrobial resistance

The newly cleared system uses advanced identification and antimicrobial susceptibility testing algorithms to support the interpretation of complex microbiological data.

The Superbug Menace - Celebrity Angels

The increasing problem of microbial resistance to conventional antibiotics is well-known, and has led to an awareness of the necessity to cut down on the use of antibiotics, as well as the urgency of developing new ones; but the Lancet report puts into the starkest terms yet the possibilities should the issue worsen. The new study by the Global Research on Antimicrobial Resistance (GRAM) Project is the first global analysis of antimicrobial resi…

Antimicrobial resistance: Q&A with CARB-X about the fight against AMR - European Biotechnology Magazine

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is an industry alliance to support research and development projects in AMR. Since its inception in 2016, CARB-X has supported 113 R&D projects across 14 countries, leading to 18 projects advancing into or completing clinical trials. EBM talked to CARB-X representatives. The post Antimicrobial resistance: Q&A with CARB-X about the fight against AMR appeared first on E…

Seasonal variations and the COVID-19 pandemic: impact on antimicrobial stewardship and antibiotic prescribing in a UK secondary care setting to combat antimicrobial resistance—a pilot study - AMR Insights

Antimicrobial resistance (AMR) remains a major global health challenge, amplified by inappropriate antibiotic use during public health crises such as the COVID-19 pandemic. This pilot study, published in Frontiers in Microbiology, explores the combined impact of seasonal variation and pandemic conditions on antimicrobial stewardship (AMS) interventions in two NHS hospitals in the UK. Using interrupted time-series analysis, we reviewed 80 patient…